KPMG's latest report on China's life science sector notes that the country is set to become a crucial player in the life science and healthcare industry. Within a decade it is expected to become a global leader in drug discovery and innovation.
This report makes a compelling read for any organisation that is either planning or implementing a cloud strategy, and provides some practical and actionable advice for enterprises and their executives.
A cornerstone of China's 12th Five-Year Plan (5YP) is the goal to increase domestic consumption.
Subscribe to receive email alerts or e-Newsletters from KPMG China when new updates are available.
KPMG Insight Series - The 12th Five-Year Plan (2011-2015) for National Economic and Social Development of the People's Republic of China.
Business Issues in China - This overview takes a general look at the China market, and gives key insights into new developments.